Convexity Labs

LYV

Convexity Analyst · LYV
medium confidenceTactical · no named thesis
Generated Jun 21, 2026

ANALYST NOTE: LIVE NATION ENTERTAINMENT, INC. (LYV) DATE: 2026-06-13 CURRENT PRICE: $171.24

1. Structural Readiness

  • State: Actionable (Forming Coil)
  • Conservative Entry: Not yet available (requires confirmed breakout).
  • Aggressive/Pre-Breakout Entry: Not applicable for a conservative strategy; the setup is currently in the accumulation/consolidation phase.
  • Breakout Level: Not yet defined (requires price action to establish the resistance zone).
  • Current Price: $171.24.
  • Extension: Not applicable (price is within the coil range, not extending beyond a breakout).
  • ATR Context: Current ATR is 2.7% (productive). This volatility is within the historical "sweet spot" (4–6% is ideal, but 2.7% indicates manageable, productive volatility for a large-cap name, well below the "extreme" >8% risk zone).

2. Thesis Layer

  • Thesis Classification: TACTICAL / Setup-Led.
  • Macro Context: There is no named secular thesis attached to this specific setup as of 2026-06-13. The investment case is not driven by a broad macro narrative (e.g., "post-pandemic recovery" or "AI disruption") but is strictly driven by the quality of the price structure (the forming coil) and the underlying business fundamentals reported in the most recent filings.

3. Business Analysis

Live Nation Entertainment, Inc. is a global leader in live entertainment, operating through three primary segments: Concerts, Ticketing, and Sponsorship & Advertising.

  • Concerts Segment: This is the dominant revenue driver, generating $20.9 billion (83% of total revenue) in 2025. The company invests nearly $15 billion annually in artist performances, more than any other entity in the industry. As of the Q1 2026 earnings call (May 5, 2026), management reported:
  • Pipeline Strength: Approximately 15,000 shows are on sale, with only ~100 cancellations (typical attrition).
  • Growth Metrics: Ticket sales are pacing up over double digits year-over-year. The company is tracking ahead of last year on show count.
  • Deferred Revenue: A critical leading indicator, event-related deferred revenue stands at $6.6 billion as of March 31, 2026, up $1.2 billion (22%) compared to March 31, 2025. Management stated, "Based on our strong pipeline... we are optimistic for continued growth in the remainder of the year."
  • Venue Expansion: Management expects to open "a couple of great amps" and other theaters in 2026, with acceleration expected in 2027 and 2028. They are leveraging venue collateral to grow their balance sheet, having utilized over EUR 600 million in venue collateral.
  • Ticketing Segment: Ticketmaster distributes 646 million tickets globally (2025 data). In Q1 2026, ticketing's deferred Gross Ticket Value (GTV) was up nearly 30% year-over-year. The company sold 80.6 million fee-bearing tickets in Q1 2026, a 4% increase over the prior year.
  • Sponsorship & Advertising: Committed sponsorship sales are up over double digits year-over-year. The segment serves 10,500 clients worldwide, including sports franchises, arenas, and festivals.
  • Fan Base: The "Venue Nation" fan count is expected to grow by double digits in 2026. As of Q1 2026, the fan base reached 23.8 million (up 7% YoY), with notable acts including Harry Styles, Bad Bunny, and AC/DC driving engagement.

4. Archetype and Conviction

  • Archetype: Quality Compounder.
  • Rationale: The company demonstrates consistent revenue growth (12% reported, 9% constant currency in Q1 2026), expanding deferred revenue balances, and a dominant market position (largest producer of live music concerts globally). The business model benefits from high barriers to entry (venue ownership, Ticketmaster dominance) and recurring revenue streams (deferred revenue).
  • Valuation Context: The financial spine indicates a Forward Consensus EPS of -0.18669 for FY1 and 2.48414 for FY2. The negative FY1 consensus likely reflects the timing of the current fiscal year's earnings recognition or specific one-time costs, while the positive FY2 projection aligns with management's guidance for strong Q3 and Q4 performance.
  • Conviction Stack:
  • Thesis Strength: Moderate (Tactical, no macro tailwind).
  • Evidence Quality: High. Multiple data points from earnings transcripts and SEC filings confirm strong momentum in ticket sales, deferred revenue, and show counts.
  • Setup Readiness: Partial. The setup is "actionable" in the sense that it is a valid structure to watch, but it is not yet a "confirmed" breakout. The 2.7% ATR suggests the stock is not in a high-volatility panic state, allowing for a clean structural formation.
  • Rerating Potential: High, contingent on the breakout. If the price breaks the resistance zone, the strong fundamental backdrop (22% growth in deferred revenue) could support a re-rating.

5. Invalidations, Strengths, and Gaps

  • What Would Strengthen: A confirmed daily close above the resistance zone (breakout) accompanied by volume. Continued confirmation of the Q3/Q4 margin guidance provided by management would also reinforce the "Quality Compounder" thesis.
  • Gaps in Evidence:
  • Breakout Level: The specific resistance level to watch for the breakout is not defined in the text.
  • FY1 EPS Negative: The negative consensus EPS for FY1 is a data point that requires context (e.g., is this due to a specific accounting change or a temporary dip?). The evidence does not explain the cause of the negative FY1 consensus, only the magnitude.

PRIVATE ANALYST CALL

Judgment: Buy Confidence: medium Key evidence: Deferred revenue up 22% YoY to $6.6B signaling strong future bookings; Ticket sales pacing up double digits; Management guidance for strong Q3/Q4 margins and AOI. Sizing hint: Position size should reflect the "forming" nature of the setup; smaller than a confirmed breakout trade, sized to allow for the volatility of a consolidation phase. Expected path: Price consolidates within the coil range while fundamentals (deferred revenue, ticket sales) continue to accumulate; eventual breakout above resistance as Q3 results confirm management's strong margin guidance. Expected horizon: 3 to 6 months, aligning with the Q3/Q4 earnings cycle and the typical duration of a forming coil breakout.

Loading chart...
Exhibit 1: LYV daily candlestick — no active setup overlay.

Source-backed evidence anchors and catalysts land once Convexity finishes coverage for LYV.

Core assumptions for this name haven't been articulated yet — they land alongside the rerating thesis.

Value picture unavailable — no financial spine on file for LYV.

Layer B fundamentals snapshot not yet available. Highlights land once Convexity finishes the classification.

Coverage: